Skip to main content
Caplight Logo









Key2Brain

Key2Brain

Private
SolnaHealthcare & Life Scienceshttps://www.key2brain.com/

Last Round

Grant

Apr 1, 2026

Total Funding Raised

$464,300

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Key2Brain is a biotechnology company that provides a platform technology for enhanced brain uptake of biologics and diagnostics for treating the central nervous system (CNS).

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

blood-brain barrier shuttleBBB shuttlebrain drug deliverybrain shuttledrug delivery platformVHH antibodiesnanobodiesCNS drug deliverysingle-domain antibodiesTransferrin Receptor targetingTfR targetingCNS therapeuticsbiotech licensingoligonucleotide deliverysiRNA deliverylysosomal storage disordersAlzheimer's disease

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Key2Brain Comparables

Compare Key2Brain with similar companies based on industry and business-model similarity.

Key2Brain comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Gate2Brain
89%
Ossianix
86%
Vect-Horus
83%

Key2Brain Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantApr 1, 2026
VC RoundOct 2, 2024
GrantNov 1, 2023
GrantMay 18, 2023

Key People

Founding team and executive leadership

Magnus Berglund

Chief Technology Officer

Executive Team

Key2Brain Investors

Notable investors and investment history

Key2Brain investors
InvestorRounds
Uppsala Innovation CentreAccelerator
Phase2Phase BiopharmaVC Round, Accelerator
VinnovaGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors grew 221% MoM, reaching 1.2K.

  • Apr 1, 2026

    $3K raised from Vinnova

Key2Brain Filings

Explore SEC and related filing metadata, where available.

Key2Brain filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Key2Brain's valuation, stock price, and market status.

Is Key2Brain a public or private company?

Key2Brain is a private company.

What is the current stock price of Key2Brain?

Key2Brain is a private company with no public stock price. No recent secondary market data is available.

How much is Key2Brain worth (valuation)?

Valuation information for Key2Brain is not publicly available.

Can I buy Key2Brain stock?

Key2Brain shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Key2Brain's last funding round?

Funding round information for Key2Brain is not publicly available.

Who are the main investors in Key2Brain?

Investor information for Key2Brain is not publicly disclosed.

Will Key2Brain IPO soon?

No public IPO plans have been announced for Key2Brain.

How can I track Key2Brain secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Key2Brain's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSolna
Employee Range14
Year Founded2020
Last FundingApr 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?